DK0969839T3 - Anhydrovinblastin til behandling af cancer - Google Patents

Anhydrovinblastin til behandling af cancer

Info

Publication number: DK0969839T3
Authority: DK; Denmark
Prior art keywords: anhydrovinblastine; cancer; treatment; vinblastine; present
Prior art date: 1997-03-04

Application number

DK98909249T

Other languages

Danish (da)

English (en)

Inventor

Bruce Schmidt

Lawrence Mayer

James Kutney

Original Assignee

Univ British Columbia

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-03-04

Filing date

1998-03-04

Publication date

2004-03-29

1997-03-04 Priority claimed from CA 2199065 external-priority patent/CA2199065A1/en

1997-05-14 Priority claimed from CA 2205314 external-priority patent/CA2205314A1/en

1998-03-04 Application filed by Univ British Columbia filed Critical Univ British Columbia

2004-03-29 Application granted granted Critical

2004-03-29 Publication of DK0969839T3 publication Critical patent/DK0969839T3/da

Links

FFRFGVHNKJYNOV-DOVUUNBWSA-N 3',4'-Anhydrovinblastine Chemical compound C([C@@H](C[C@]1(C(=O)OC)C=2C(=CC3=C([C@]45[C@H]([C@@]([C@H](OC(C)=O)[C@]6(CC)C=CCN([C@H]56)CC4)(O)C(=O)OC)N3C)C=2)OC)C=C(C2)CC)N2CCC2=C1NC1=CC=CC=C21 FFRFGVHNKJYNOV-DOVUUNBWSA-N 0.000 title abstract 2
206010028980 Neoplasm Diseases 0.000 title abstract 2
201000011510 cancer Diseases 0.000 title abstract 2
229950001104 anhydrovinblastine Drugs 0.000 title 1
JXLYSJRDGCGARV-XQKSVPLYSA-N vincaleukoblastine Chemical class C([C@@H](C[C@]1(C(=O)OC)C=2C(=CC3=C([C@]45[C@H]([C@@]([C@H](OC(C)=O)[C@]6(CC)C=CCN([C@H]56)CC4)(O)C(=O)OC)N3C)C=2)OC)C[C@@](C2)(O)CC)N2CCC2=C1NC1=CC=CC=C21 JXLYSJRDGCGARV-XQKSVPLYSA-N 0.000 abstract 2
JXLYSJRDGCGARV-WWYNWVTFSA-N Vinblastine Natural products O=C(O[C@H]1[C@](O)(C(=O)OC)[C@@H]2N(C)c3c(cc(c(OC)c3)[C@]3(C(=O)OC)c4[nH]c5c(c4CCN4C[C@](O)(CC)C[C@H](C3)C4)cccc5)[C@@]32[C@H]2[C@@]1(CC)C=CCN2CC3)C JXLYSJRDGCGARV-WWYNWVTFSA-N 0.000 abstract 1
229940034982 antineoplastic agent Drugs 0.000 abstract 1
239000002246 antineoplastic agent Substances 0.000 abstract 1
125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
230000001225 therapeutic effect Effects 0.000 abstract 1
229960003048 vinblastine Drugs 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Steroid Compounds (AREA)

DK98909249T 1997-03-04 1998-03-04 Anhydrovinblastin til behandling af cancer DK0969839T3 (da)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
CA 2199065 CA2199065A1 (en)	1997-03-04	1997-03-04	Anhydrovinblastine for the treatment of cancer
CA 2205314 CA2205314A1 (en)	1997-03-04	1997-05-14	Anhydrovinblastine for the treatment of cervical and lung cancer
CA002219095A CA2219095A1 (en)	1997-03-04	1997-10-24	Anhydrovinblastine for the treatment of cervical and lung cancer
PCT/CA1998/000195 WO1998039004A1 (en)	1997-03-04	1998-03-04	Anhydrovinblastine for the treatment of cervical and lung cancer

Publications (1)

Publication Number	Publication Date
DK0969839T3 true DK0969839T3 (da)	2004-03-29

Family

ID=27170289

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK98909249T DK0969839T3 (da)	1997-03-04	1998-03-04	Anhydrovinblastin til behandling af cancer

Country Status (10)

Country	Link
US (2)	US6326376B1 (de)
EP (1)	EP0969839B1 (de)
AT (1)	ATE254460T1 (de)
AU (1)	AU6388598A (de)
CA (1)	CA2219095A1 (de)
DE (1)	DE69819875T2 (de)
DK (1)	DK0969839T3 (de)
ES (1)	ES2212272T3 (de)
NZ (1)	NZ337752A (de)
WO (1)	WO1998039004A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2005528404A (ja) *	2002-04-16	2005-09-22	アクセス・オンコロジー・インコーポレイテッド	癌治療用アンヒドロビンブラスチン

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4279817A (en)	1975-05-30	1981-07-21	The United States Of America As Represented By The Department Of Health & Human Services	Method for producing dimer alkaloids
US4029663A (en)	1975-07-10	1977-06-14	Eli Lilly And Company	Dimeric anhydro-vinca derivatives
US4307100A (en) *	1978-08-24	1981-12-22	Agence Nationale De Valorisation De La Recherche (Anvar)	Nor bis-indole compounds usable as medicaments
US4778885A (en) *	1986-09-18	1988-10-18	Allelix Inc.	Production of alkaloid dimers using ferric ion
US5037977A (en) *	1988-08-11	1991-08-06	Mitsui Petrochemical Industries Ltd.	Method for production of dimeric alkaloids
US6011041A (en)	1995-07-28	2000-01-04	University Of British Columbia	Use of anhydrovinblastine

1997
- 1997-10-24 CA CA002219095A patent/CA2219095A1/en not_active Abandoned
1998
- 1998-03-04 EP EP98909249A patent/EP0969839B1/de not_active Expired - Lifetime
- 1998-03-04 US US09/380,540 patent/US6326376B1/en not_active Expired - Fee Related
- 1998-03-04 ES ES98909249T patent/ES2212272T3/es not_active Expired - Lifetime
- 1998-03-04 DK DK98909249T patent/DK0969839T3/da active
- 1998-03-04 NZ NZ337752A patent/NZ337752A/xx unknown
- 1998-03-04 AU AU63885/98A patent/AU6388598A/en not_active Abandoned
- 1998-03-04 AT AT98909249T patent/ATE254460T1/de not_active IP Right Cessation
- 1998-03-04 DE DE69819875T patent/DE69819875T2/de not_active Expired - Fee Related
- 1998-03-04 WO PCT/CA1998/000195 patent/WO1998039004A1/en not_active Ceased
2001
- 2001-09-04 US US09/946,149 patent/US20020103218A1/en not_active Abandoned

Also Published As

Publication number	Publication date
AU6388598A (en)	1998-09-22
DE69819875T2 (de)	2004-11-11
WO1998039004A1 (en)	1998-09-11
HK1026610A1 (en)	2000-12-22
US20020103218A1 (en)	2002-08-01
CA2219095A1 (en)	1998-09-04
ES2212272T3 (es)	2004-07-16
US6326376B1 (en)	2001-12-04
NZ337752A (en)	2001-08-31
EP0969839A1 (de)	2000-01-12
EP0969839B1 (de)	2003-11-19
ATE254460T1 (de)	2003-12-15
DE69819875D1 (de)	2003-12-24

Publication	Publication Date	Title
DE60030741D1 (de)	2006-10-26	Chinazoline verbindungen als heilmittel
PT1187918E (pt)	2006-08-31	Antagonistas de tek
ATE277929T1 (de)	2004-10-15	Immunsuppressive wirkungen von pteridinderivaten
EP0939627A4 (de)	2000-10-04	Pentafluorobenzensulfonamide und analoge
PT1115701E (pt)	2003-09-30	Ureias de arilsulfonanilida
BR9707819A (pt)	1999-07-27	Imunogenos peptidicos
DK0841949T3 (da)	2006-08-21	Anvendelse af saccharid-konjugater
ATE505208T1 (de)	2011-04-15	Rezeptorbindende konjugate
TR199901104T2 (xx)	1999-07-21	Farmas�tik bile�ikler.
EA200200545A1 (ru)	2002-12-26	Онколитические комбинации для лечения рака
ATE243205T1 (de)	2003-07-15	C7-taxan-derivate und diese enthaltende pharmazeutische zusammensetzungen
DK0969839T3 (da)	2004-03-29	Anhydrovinblastin til behandling af cancer
DE69911017D1 (en)	2003-10-09	Arylsulfonanilid-phosphate
ES2088661T3 (es)	1996-08-16	Bis-naftalimidas fuertemente solubles en agua utiles como agentes anti-cancerigenos.
PT1210350E (pt)	2004-10-29	Esteres de sdz-rad soluveis em agua
PT1551850E (pt)	2006-10-31	2 oxo-voruscharina e seus derivados